AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Sitalite-M 50/1000 Tablet

Prescription Icon
Prescription Required

Marketer

Griffins Life Sciences Pvt. Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview Sitalite-M 50/1000 Tablet

Diabetics with type 2 mellitus may find relief from elevated blood glucose with GlucoTwin 50/1000, a dual-action tablet. This medication mitigates the risk of severe diabetic complications like renal impairment and vision loss, potentially lowering cardiovascular event risk. GlucoTwin 50/1000 can be used as a standalone therapy or in conjunction with other antidiabetic agents. Optimal results are achieved when combined with a balanced diet and regular physical activity. Dosage is individualized based on your health status, glycemic control, and existing medications. Consuming it with meals minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under medical supervision. Adherence to your physician's dietary and exercise plan is crucial for effective diabetes management; lifestyle choices are integral to overall control. Commonly reported adverse effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia, particularly when used with insulin or sulfonylureas, is a potential risk; therefore, understanding its symptoms and management is essential. This medication isn't suitable for all individuals. Prior to commencing treatment, inform your doctor of any pre-existing kidney, liver, or heart conditions, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating women should seek medical counsel before initiating therapy. Potential drug interactions exist; therefore, disclose all medications to your doctor to ensure treatment safety. Alcohol should be limited due to its potential to reduce blood glucose. Your doctor will monitor renal function and blood sugar levels throughout the treatment course.

Uses of Sitalite-M 50/1000 Tablet

Managing type 2 diabetes

Major Benefits of Sitalite-M 50/1000 Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Sitalite-M 50/1000 with a meal.

Common Side effects of Sitalite-M 50/1000 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitalite-M 50/1000 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sitalite-M 50/1000 Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

How Sitalite-M 50/1000 Tablet works:

Sitalite-M 50/1000 tablets combine sitagliptin and metformin to manage blood sugar. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sitalite-M 50/1000 Tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Sitalite-M 50/1000 tablets during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers before prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Sitalite-M 50/1000 tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitalite-M 50/1000 Tablet cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

Patients with liver disorders should likely refrain from using Sitalite-M 50/1000 tablets due to potential safety concerns. A physician's consultation is advised.

What if you forget to take Sitalite-M 50/1000 Tablet :

Should you forget to take a Sitalite-M 50/1000 Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitalite-M 50/1000 Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Sitalite-M 50/1000 Tablet

Sitalite-M 50/1000 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged Sitalite-M 50/1000 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), and urinary or cognitive issues. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Sitalite-M 50/1000 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitalite-M 50/1000 Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitalite-M 50/1000 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (like Sitalite-M 50/1000) can rarely cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also called Metformin-associated lactic acidosis or MALA). This risk is higher in patients with kidney disease, older adults, and heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, stop taking Sitagliptin/Metformin and seek immediate medical attention.
Sitalite-M 50/1000 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitalite-M 50/1000 Tablet may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to Sitalite-M 50/1000 Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitalite-M 50/1000 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (like Sitalite-M 50/1000) can rarely cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also called Metformin-associated lactic acidosis, or MALA). This risk is higher in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged Sitalite-M 50/1000 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication. Keep out of reach of children, pets, and others.
Sitalite-M 50/1000 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitalite-M 50/1000 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Sitalite-M 50/1000 Tablets are contraindicated in patients with known allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitalite-M 50/1000 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/metformin (like Sitalite-M 50/1000) can rarely cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA). This risk is increased in patients with kidney disease, the elderly, and heavy alcohol users, so it's avoided in these groups. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, stop taking Sitagliptin/metformin and seek immediate medical attention.
Prolonged Sitalite-M 50/1000 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitalite-M 50/1000 Tablet
128
MRP 149
14% off